XHLD vs REVG vs HIMS vs WNC vs SKIN

For growth investors, Hims & Hers Health, Inc.

(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -20. 8% for Wabash National Corporation (WNC). Wabash National Corporation (WNC) offers the better valuation at 1. 5x trailing P/E, making it the more compelling value choice. Analysts rate REV Group, Inc. (REVG) a "Hold" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Wabash National Corporation (WNC) is the cheapest at 1.

5x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, REV Group, Inc. is actually cheaper at 17. 2x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, REV Group, Inc.

(REVG) delivered a total return of +261. 2%, compared to -92. 9% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: HIMS returned +188. 5% versus SKIN's -94. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), REV Group, Inc.

(REVG) is the lower-risk stock at 1. 48β versus Hims & Hers Health, Inc. 's 2. 48β — meaning HIMS is approximately 68% more volatile than REVG relative to the S&P 500. On balance sheet safety, REV Group, Inc. (REVG) carries a lower debt/equity ratio of 13% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hims & Hers Health, Inc.

(HIMS) is pulling ahead at 59. 0% versus -20. 8% for Wabash National Corporation (WNC). On earnings-per-share growth, the picture is similar: Wabash National Corporation grew EPS 179. 2% year-over-year, compared to -376. 7% for TEN Holdings, Inc. Common Stock. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Wabash National Corporation (WNC) is the more profitable company, earning 13.

7% net margin versus -628. 5% for TEN Holdings, Inc. Common Stock — meaning it keeps 13. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WNC leads at 20. 8% versus -432. 5% for XHLD. At the gross margin level — before operating expenses — XHLD leads at 78. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, REV Group, Inc.

(REVG) trades at 17. 2x forward P/E versus 58. 3x for Hims & Hers Health, Inc. — 41. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SKIN: 42. 9% to $1. 30.

In this comparison, WNC (4.

2% yield), REVG (0. 4% yield) pay a dividend. XHLD, HIMS, SKIN do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Wabash National Corporation (WNC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (4.

2% yield). TEN Holdings, Inc. Common Stock (XHLD) carries a higher beta of 1. 98 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (WNC: -24. 9%, XHLD: -79. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (XHLD (Communication Services) and REVG (Industrials) and HIMS (Healthcare) and WNC (Industrials) and SKIN (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: XHLD is a small-cap quality compounder stock; REVG is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock; WNC is a small-cap deep-value stock; SKIN is a small-cap quality compounder stock. WNC pays a dividend while XHLD, REVG, HIMS, SKIN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.